Search results
Showing 6931 to 6945 of 7680 results
Ovarian (epithelial), fallopian, peritoneal cancer - paclitaxel (encapsulated in XR-17 [ID565]
Discontinued [GID-TA11209]
Multiple myeloma (untreated) - carfilzomib (with melphalan and prednisone) [ID1133]
Discontinued [GID-TA11210]
Otilimab for treating moderate to severe rheumatoid arthritis [ID6171]
In development [GID-TA11108] Expected publication date: TBC
Nintedanib for treating fibrosing interstitial lung disease in people aged 6 to 17 [ID6194]
In development [GID-TA11126] Expected publication date: TBC
Atezolizumab (Tecentriq) + bevacizumab (Avastin) + chemotherapy for ovarian cancer TS ID 10701
In development [GID-TA11157] Expected publication date: TBC
Hypercholesterolaemia (primary), dyslipidaemia (mixed) - anacetrapib [ID1165]
Discontinued [GID-TA11175]
Idasanutlin with cytarabine for treating relapsed or refractory acute myeloid leukaemia [ID1597]
Discontinued [GID-TA10494]
Entinostat for treating hormone receptor-positive breast cancer after hormonal therapy [ID1260]
Discontinued [GID-TA10309]
Nivolumab with ipilimumab for neoadjuvant treatment of early non-small-cell lung cancer [ID3756]
Discontinued [GID-TA10631]
Empagliflozin for type 1 Diabetes Mellitus, adjunct to insulin ID1275
Discontinued [GID-TA10375]
PEGPH20 with nab-paclitaxel and gemcitabine for treating metastatic pancreatic cancer ID1502
Discontinued [GID-TA10402]
Discontinued [GID-TA10689]
Pelareorep for treating metastatic malignant melanoma after previous therapy [ID941]
Discontinued [GID-TA10686]
Pelareorep for treating relapsed or refractory multiple myeloma [ID1028]
Discontinued [GID-TA10687]